| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |